These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 9827351)
1. In vitro reversal of glutathione-S-transferase-mediated resistance in canine osteosarcoma (COS31) cells. Shoieb AM; Hahn KA; Van Laack RL; Barnhill MA In Vivo; 1998; 12(5):455-62. PubMed ID: 9827351 [TBL] [Abstract][Full Text] [Related]
2. An in vivo/in vitro experimental model system for the study of human osteosarcoma: canine osteosarcoma cells (COS31) which retain osteoblastic and metastatic properties in nude mice. Shoieb AM; Hahn KA; Barnhill MA In Vivo; 1998; 12(5):463-72. PubMed ID: 9827352 [TBL] [Abstract][Full Text] [Related]
3. Inhibitors of intracellular chloride regulation induce cisplatin resistance in canine osteosarcoma cells. Yarbrough JW; Merryman JI; Barnhill MA; Hahn KA In Vivo; 1999; 13(5):375-83. PubMed ID: 10654189 [TBL] [Abstract][Full Text] [Related]
4. Augmentation of cisplatin sensitivity in cisplatin-resistant human bladder cancer cells by modulating glutathione concentrations and glutathione-related enzyme activities. Byun SS; Kim SW; Choi H; Lee C; Lee E BJU Int; 2005 May; 95(7):1086-90. PubMed ID: 15839938 [TBL] [Abstract][Full Text] [Related]
5. Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma. Pasello M; Michelacci F; Scionti I; Hattinger CM; Zuntini M; Caccuri AM; Scotlandi K; Picci P; Serra M Cancer Res; 2008 Aug; 68(16):6661-8. PubMed ID: 18701490 [TBL] [Abstract][Full Text] [Related]
6. Role of glutathione in cisplatin resistance in osteosarcoma cell lines. Komiya S; Gebhardt MC; Mangham DC; Inoue A J Orthop Res; 1998 Jan; 16(1):15-22. PubMed ID: 9565068 [TBL] [Abstract][Full Text] [Related]
7. Biodegradable cisplatin polymer in limb-sparing surgery for canine osteosarcoma. Withrow SJ; Liptak JM; Straw RC; Dernell WS; Jameson VJ; Powers BE; Johnson JL; Brekke JH; Douple EB Ann Surg Oncol; 2004 Jul; 11(7):705-13. PubMed ID: 15231525 [TBL] [Abstract][Full Text] [Related]
8. Characterization of new potential anticancer drugs designed to overcome glutathione transferase mediated resistance. Johansson K; Ito M; Schophuizen CM; Mathew Thengumtharayil S; Heuser VD; Zhang J; Shimoji M; Vahter M; Ang WH; Dyson PJ; Shibata A; Shuto S; Ito Y; Abe H; Morgenstern R Mol Pharm; 2011 Oct; 8(5):1698-708. PubMed ID: 21851097 [TBL] [Abstract][Full Text] [Related]
9. Sensitization of human melanoma cells to the cytotoxic effect of melphalan by the glutathione transferase inhibitor ethacrynic acid. Hansson J; Berhane K; Castro VM; Jungnelius U; Mannervik B; Ringborg U Cancer Res; 1991 Jan; 51(1):94-8. PubMed ID: 1988111 [TBL] [Abstract][Full Text] [Related]
10. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme. Wang W; Liu G; Zheng J Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556 [TBL] [Abstract][Full Text] [Related]
11. The tyrosine kinase inhibitor sorafenib decreases cell number and induces apoptosis in a canine osteosarcoma cell line. Wolfesberger B; Tonar Z; Gerner W; Skalicky M; Heiduschka G; Egerbacher M; Thalhammer JG; Walter I Res Vet Sci; 2010 Feb; 88(1):94-100. PubMed ID: 19665156 [TBL] [Abstract][Full Text] [Related]
12. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines. Robson H; Meyer S; Shalet SM; Anderson E; Roberts S; Eden OB Med Pediatr Oncol; 2002 Dec; 39(6):573-80. PubMed ID: 12376980 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of cytotoxic treatment of patients with osteosarcoma by an in vitro chemoresistance assay. Agiostratidou G; Demertzis N; Gonos ES Anticancer Res; 2000; 20(5B):3603-8. PubMed ID: 11131668 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of 5-lipoxygenase expression in canine osteosarcoma and the effects of a dual 5-lipoxygenase/cyclooxygenase inhibitor on osteosarcoma cells in vitro and in vivo. Goupil RC; Bushey JJ; Peters-Kennedy J; Wakshlag JJ Vet Pathol; 2012 Sep; 49(5):802-10. PubMed ID: 22287649 [TBL] [Abstract][Full Text] [Related]
15. In vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone. Shoieb AM; Elgayyar M; Dudrick PS; Bell JL; Tithof PK Int J Oncol; 2003 Jan; 22(1):107-13. PubMed ID: 12469192 [TBL] [Abstract][Full Text] [Related]
16. Use of an artificial lymphatic system during carboplatin infusion to improve canine osteosarcoma blood flow and clinical response. DiResta GR; Aiken SW; Brown HK; Bergman PJ; Hohenhaus A; Ehrhart EJ; Baer K; Healey JH Ann Surg Oncol; 2007 Aug; 14(8):2411-21. PubMed ID: 17503157 [TBL] [Abstract][Full Text] [Related]
17. Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistance. Ang WH; Khalaila I; Allardyce CS; Juillerat-Jeanneret L; Dyson PJ J Am Chem Soc; 2005 Feb; 127(5):1382-3. PubMed ID: 15686364 [TBL] [Abstract][Full Text] [Related]
18. Toxicity and efficacy of cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma. Chun R; Garrett LD; Henry C; Wall M; Smith A; Azene NM J Am Anim Hosp Assoc; 2005; 41(6):382-7. PubMed ID: 16267062 [TBL] [Abstract][Full Text] [Related]
19. Haloenol lactone: a new synergist of chemotherapy in vitro. Zheng J; Wurz GT; Cadman TB; Degregorio MW; Jones AD; Hammock BD Biochem Biophys Res Commun; 1997 Dec; 241(1):13-7. PubMed ID: 9405226 [TBL] [Abstract][Full Text] [Related]
20. Amine oxidase, spermine, and hyperthermia induce cytotoxicity in P-glycoprotein overexpressing multidrug resistant Chinese hamster ovary cells. Lord-Fontaine S; Agostinelli E; Przybytkowski E; Averill-Bates DA Biochem Cell Biol; 2001; 79(2):165-75. PubMed ID: 11310564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]